To give your immune system a fighting chance with inflammatory arthritis such as psoriatic arthritis, rheumatoid arthritis, or ankylosing spondylitis, it is important that you get regular vaccinations and stay up to date with them.
One of the biggest questions we hear from our patients relates to the side effects of their medications. Here are some common side effects that you should know about with biologic medications.
Victoria Ruffing, RN, CCRP discusses the risks and benefits of biologic medications for rheumatic disease patients.
Apremilast (Otezla®) received FDA approval on March 21, 2014 for the treatment of adults with active psoriatic arthritis (PsA). It is the first oral medication in the U.S. with an approved indication for the treatment of PsA. The recommended dose is 30 mg BID
OTREXUP™ (methotrexate) injection was recently approved by the U.S. Food and Drug Administration.
It is indicated for adults with severe, active rheumatoid arthritis, or children with active polyarticular juvenile idiopathic arthritis who have failed first line therapies. It is also indicated for severe, recalcitrant, disabling psoriasis.
Clifton Bingham, MD and Vicky Ruffing, RN discuss the Seasonal and Novel N1N1 flu and potential impact on the rheumatology community. Information is focused on the immunizations, delivery systems, and targeted populations.